8-K: Lifeway Foods Bolsters Board, Rejects Dissident Nominees

Lifeway Foods, Inc. announced new board appointments and strongly refuted dissident director nominations, citing ethical concerns and financial distress of the nominees.

Summary

• Lifeway Foods' Board of Directors set its size at nine directors and appointed Kirk Chartier and Susan Hultquist as new directors, effective November 26, 2025.
• The company issued a press release on December 1, 2025, responding to Edward Smolyansky's intent to nominate George Sent and himself for election to the Board, deeming them unfit to serve.
• Allegations against Edward Smolyansky include termination for cause as COO in 2022, intoxication during duties, an emergency protection order against him, founding a competitor, defaulting on a $10.4 million mortgage in 2025, and creating false social media accounts to post negative statements about Lifeway.
• Ludmila Smolyansky, Edward's mother, is facing over $2.3 million in federal and state tax liens.
• The company criticized George Sent, a former Lead Independent Director, for aligning with the dissident despite his prior role in investigating Edward Smolyansky's misconduct.
• The Annual Meeting date was changed from December 16, 2025, to December 29, 2025, with the definitive proxy statement filed and mailed on December 1, 2025.
• Lifeway highlighted strong financial performance, including a 788% total shareholder return over the past five years, ~123% revenue growth since FY2019, and six years of uninterrupted quarterly net sales growth.
• Q3 2025 net sales reached $57.1 million, a 29% volume-led increase, with a 300 basis point gross margin expansion and 19% net income growth.
• The Board has undertaken a refreshment process, adding independent directors and entering a Cooperation Agreement with Danone North America PBC, which includes further board changes by the 2026 Annual Meeting to ensure a majority of new independent members.

Sentiment

Score: 7

Explanation: The company demonstrates strong financial performance and proactive corporate governance, including significant board refreshment. However, the ongoing, highly contentious proxy fight with a dissident shareholder, involving serious allegations, introduces a notable element of uncertainty and potential distraction.

Positives

• Achieved 788% total shareholder return over the past five years, significantly outperforming peers in the Russell 3000 Food Producers Index and the S&P 500.
• Reported ~123% revenue growth since FY2019, demonstrating strong top-line expansion.
• Recorded six years of uninterrupted quarterly net sales growth, culminating in a record-breaking Q3 2025.
• Q3 2025 net sales increased by 29% on a volume-led comparable basis to $57.1 million, driven by flagship Lifeway Kefir.
• Expanded gross margin by 300 basis points and grew net income by 19% in Q3 2025, reflecting disciplined operational execution.
• Proactive board refreshment process has added independent directors with expertise in accounting, finance, public company governance, and the 'good for you food' consumer product business.
• Entered into a Cooperation Agreement with Danone North America PBC, which includes the appointment of new independent board members and a plan for future board composition to ensure majority independence.

Negatives

• The company is facing a contentious proxy fight with Edward Smolyansky, who intends to nominate himself and George Sent for the Board.
• Edward Smolyansky was terminated for cause as COO in 2022 and is alleged to have engaged in misconduct, including intoxication during duties and creating false social media accounts against the company.
• Edward Smolyansky is subject to an emergency protection order prohibiting communication with or proximity to Lifeway's CEO, Julie Smolyansky.
• Edward Smolyansky defaulted on a $10.4 million mortgage in 2025, and his mother, Ludmila Smolyansky, faces over $2.3 million in federal and state tax liens, which the company suggests are fueling demands for a quick sale.
• George Sent, a former Lead Independent Director who investigated Edward Smolyansky's misconduct, has now aligned with the dissident, raising concerns about his judgment and ethics.
• Institutional Shareholder Services (ISS) previously recommended shareholders 'DO NOT VOTE' on proposals put forth by the dissident group, including Mr. Sent, citing a lack of a compelling case for change or a plan for governance/operational improvement.

Risks

• The ongoing dissident challenge could create instability, distract management, and incur significant costs related to the proxy solicitation.
• The company's forward-looking statements are subject to risks including price competition, decisions of customers or consumers, actions of competitors, changes in commodity pricing, effects of government regulation, possible delays in new product introductions, and customer acceptance of products and services.
• The personal financial distress of the dissident nominees could lead them to advocate for actions, such as a quick sale of the company, that are not in the best interests of all shareholders.
• The allegations of misconduct and ethical concerns against the dissident nominees, if they were to gain board seats, could negatively impact the company's reputation and governance.

Future Outlook

The company is well-positioned for continued success, whether as an independent entity or through a transaction that delivers compelling value for shareholders. The Board is committed to ongoing refreshment and strategic oversight.

Management Comments

• The track record of the Dissident Nominees demonstrates they are unfit to serve on the Company's Board of Directors and lead the Company and pose a clear risk to shareholder value.
• The Dissident Nominees have disqualifying issues raising ethical concerns.
• The Dissident's personal financial distress and that of Ludmila Smolyansky, his mother, and the limited amount of shares they can sell in the aggregate each calendar year seem to be fueling their demands for a sale of the Company at any price and could cause the Dissident Nominees to vote in ways that help the Dissident and his mother personally but are not in the best interests of other shareholders.
• Lifeway's Board and management have delivered results, including 788% total shareholder return over the past five years and ~123% revenue growth since FY2019.
• The Board is committed to refreshing the Board in a thoughtful manner, replacing long-serving directors and adding new directors whose skills and knowledge increase the Board's independence, breadth of experience, and effectiveness.
• Under the current Board as adjusted in 2026, Lifeway is well positioned for continued success, whether as an independent company or in a transaction that achieves a compelling value for Lifeway shareholders.
• We urge you to reject the Dissident's solicitation on behalf of the Dissident Nominees and the Dissident's proposal and protect the value of your investment.

Industry Context

Lifeway Foods operates in the growing 'good for you food' and fermented probiotic products market, specifically as a leading U.S. supplier of kefir. The company's strong financial performance, including significant revenue growth and market outperformance, suggests it is capitalizing on consumer trends towards health-conscious food and beverage choices. The board refreshment efforts, including adding directors with expertise in growing and selling businesses and 'good for you food' products, align with strategic positioning within this dynamic industry.

Comparison to Industry Standards

• Lifeway's 788% total shareholder return over the past five years (ended September 23, 2024) dramatically outperformed its peers in the Russell 3000 Food Producers Index and the S&P 500.
• Institutional Shareholder Services (ISS) noted in July 2025 that Lifeway's financial performance has been directionally positive and its share price rallied over the preceding year on multiple positive earnings announcements, with total shareholder return significantly outperforming peers.

Management Changes

Corporate Governance

Legal Proceedings

• Edward Smolyansky is subject to an emergency protection order prohibiting him from communicating with or going near Lifeway's CEO, Julie Smolyansky, as mentioned in the context of his past misconduct.

Stakeholder Impact

• Shareholders: The ongoing proxy fight and allegations against dissident nominees create uncertainty but the company's strong financial performance and proactive governance efforts aim to protect and enhance shareholder value. The change in the Annual Meeting date impacts shareholder voting timelines.
• Management and Board: The Board is actively engaged in refreshment and defending against the dissident, requiring significant time and resources. The CEO is directly impacted by the emergency protection order against Edward Smolyansky.
• Employees: Potential for distraction and uncertainty due to the governance dispute, though strong financial results may provide stability.
• Customers: No direct impact mentioned, but a stable and well-governed company is generally better positioned to serve customers.

Next Steps

• The Annual Meeting of shareholders will be held on December 29, 2025.
• Pol Sikar, the longest-serving director, will not be nominated for re-election at the 2025 Annual Meeting.
• Jason Scher, the next longest-serving director, will not be nominated for re-election at the 2026 Annual Meeting.
• At or prior to the 2026 Annual Meeting, the Board will be made up of a majority of New Independent Board Members.

Key Dates

Recommendation

While Lifeway Foods demonstrates exceptional financial performance, including strong revenue growth and total shareholder return, and has proactively strengthened its corporate governance through board refreshment and a cooperation agreement with Danone, the ongoing and highly contentious proxy fight introduces significant short-term uncertainty. The serious allegations against the dissident nominees, coupled with their stated intent to push for a sale 'at any price,' could create volatility and distraction. A seasoned investor would likely 'hold' to monitor the outcome of the Annual Meeting and the resolution of this governance dispute before making a more definitive investment decision, despite the strong underlying business fundamentals.

Keywords

Lifeway Foods, LWAY, SEC filing, 8-K, Board of Directors, Corporate Governance, Proxy Fight, Shareholder Activism, Kefir, Probiotic Products, Financial Performance, Net Sales, Gross Margin, Net Income, Total Shareholder Return, Danone, Nasdaq